Antiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.
Katherine Saunders, M.D.
Advertisement
Articles by Katherine Saunders, M.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
The Drug Price Paradox: PBMs, Pharmacies, and the Path to Affordability
2
Zepbound Lowers Health Care Costs in Older Adults With Obesity
3
Pharmacy Technician Shines Light on Expanding Role
4
Updated Guideline Refines Approach to Migraine Prevention in Adults
5